Regulation 2 Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
The Misuse of Drugs Regulations (Northern Ireland) 2002f1 are amended as follows
In paragraph 1(a) of Schedule 3 (controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 22, 23, 24, 26 and 27)—
after “Flunitrazepam” insert—
“Gabapentin (1–(aminomethyl)cyclohexaneacetic acid)”, and
after “Pipradrol” insert—
“Pregabalin ((S)–3–(aminomethyl)-5-methylhexanoic acid)”.
In paragraph 3 of Schedule 3, for “Any ester or ether of pipradrol.” substitute—
“Any—
(a)ester or ether of pipradrol; or
(b)ester of gabapentin (1–(aminomethyl)cyclohexaneacetic acid) or pregabalin ((S)–3–(aminomethyl)-5-methylhexanoic acid)”.
Annotations
Footnotes
- f1
-
S.R. 2002 No.1. Relevant amending Regulations are S.R. 2018 Nos. 173 and 4, S.R. 2016 No. 29, S.R. 2015 No. 227, S.R. 2015 No. 53, S.R. 2014 Nos. 261, 158 and 21, S.R. 2013 No. 78, S.R. 2012 No. 213, S.R. 2011 No. 153, S.R. 2010 Nos. 247 and 148, S.R. 2009 No. 390, S.R. 2007 No. 348, S.R. 2005 No. 360 and S.R. 2003 No. 314